Patents
Patents for C07D 221 - Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups (10,931)
06/2007
06/14/2007US20070135639 red pigments has superior dispersibility in binder, non-flocculated, produce a desired hue; contains anthraquinone group; printing inks, paints, colorants for various plastics, toner
06/14/2007US20070134161 Methods of determining beta-iii tubulin expression
06/13/2007EP1795527A1 Carbamoyl-substituted spiro derivative
06/13/2007EP1794165A1 Preparation of opiate analgesics by reductive alkylation
06/13/2007EP1794129A2 Synthesis by chiral diamine-mediated asymmetric alkylation
06/13/2007CN1980927A Pyrazolopyridine derivatives
06/13/2007CN1980791A Perylene n-type semiconductors and related devices
06/13/2007CN1321121C Post processing method for preparing levo-ofloxacin
06/13/2007CN1321120C Phenoxazones, preparing process and pharmaceutical uses thereof
06/12/2007US7229989 When used in photochromic eyeglass lenses, produce essentially blue color tones which have a high darkening capacity
06/12/2007CA2130828C Non-azo naphthalimide dyes and uses for same
06/07/2007WO2007030940A3 Methods of modulating neurotrophin-mediated activity
06/07/2007WO2007002258A3 Benzocycloheptapyridines as inhibitors of the receptor tyrosine kinase met
06/07/2007CA2632181A1 Heterocyclic-substituted bis-1,8 naphthalimide compounds, antibody drug conjugates, and methods of use
06/06/2007EP1792897A2 Intercalators having affinity for DNA and methods of use
06/06/2007CN1976936A Tetrahydroquinolines
06/06/2007CN1976932A Fused quinoline derivative and use thereof
06/06/2007CN1974574A Novel tricyclic spiropiperidines or spiropyrrolidines
06/06/2007CN1319971C Camptothecine derivatives and their use
06/06/2007CN1319969C Fungicides
06/05/2007USRE39680 Sleep disorders associated with 5-HT2A serotonin receptor modulation; antagonists or agonists
06/05/2007USRE39679 Substituted heterocycle fused gamma-carbolines
06/05/2007CA2225528C Novel camptothecin analogues, preparation methods therefor, use thereof as drugs, and pharmaceutical compositions containing said analogues
05/2007
05/31/2007WO2005099688A3 Cyclic compounds
05/31/2007US20070123543 Novel compounds
05/31/2007US20070119000 Cationic naphthalene dyes and colorants for keratin fibers, particularly human hair; 4-{(E)-[(1,3-diketo-2,3-dihydro-1H-benzo[de]isoquinolin-6-yl)imino]methyl}-1-(2-hydroxyethyl)pyridinium bromide, for example
05/30/2007EP1789047A2 Treatment of diseases using nalmefene and its analgos
05/30/2007EP0819121B1 Tricyclic compounds useful for inhibition of g-protein function and for treatment of proliferative diseases
05/30/2007CN1972941A Pyrrolopyrimidine and pyrrolopyridine derivatives substituted with tetrahydropyridine as CRF antagonists
05/30/2007CN1972940A Pyrrolopyrimidine and pyrrolopyridine derivatives substituted with a cyclic amino group as CRF antagonists
05/30/2007CN1318428C Thiophenopyridine substituted acetyl hyarazine derivative
05/30/2007CN1318421C Non-nucleoside reverse transcriptase inhibitors
05/30/2007CN1318420C Dipyridodiazepinones as reverse transcriptase inhibitors
05/30/2007CN1318419C 1,6,9,14-tetrasubstituted terrylene tetracarboxylic acid diimides
05/29/2007US7223864 2-hydroxyethidium, methods of preparation and uses thereof
05/29/2007US7223771 Inhibit the secretion of gastric acid; methyl 2,3-dimethyl-9-(2-ethyl-6-methyl-phenyl)-7H-8,9-dihydro-pyrano[2,3-c]-imidazo[1,2-a]pyridine-6-carboxylate for example; gastrointestinal inflammatory diseases such as gastric ulcers; high selectivity of action, side effect reduction, good enteral activity
05/29/2007US7223750 Therapy for disease caused by nicotinic receptors; cognition activatrors; central nervous system disorders
05/29/2007US7223301 Anthrapyridone compound, water-based magenta ink composition and inkjet recording method
05/24/2007WO2007059008A2 N-substituted indenoisoquinolines and syntheses thereof
05/24/2007US20070117982 Method for producing 1,2-unsaturated azasteroids
05/24/2007US20070117836 Napthalimide derivatives, methods for their production and pharmaceutical compositions therefrom
05/24/2007US20070114494 Tetrabenzodiazadiketoperylene pigments for laser marking
05/24/2007CA2629530A1 N-substituted indenoisoquinolines and syntheses thereof
05/23/2007EP1787992A1 Pyrrolopyrimidine and pyrrolopyridine derivatives substituted with cyclic amino group
05/23/2007EP1787985A1 Azonafide derivatives, methods for their production and pharmaceutical compositions therefrom
05/23/2007CN1968932A Processes for preparing 6-alkyl-5-arylsulfonyl-dihydrophenanthridines
05/23/2007CN1968931A Pyridine analogs as C5A antagonists
05/23/2007CN1968930A Bicyclic, nitrogen-containing heterocycles aromatase inhibitors
05/23/2007CN1317280C Novel diazabicyclic aryl derivatives
05/23/2007CN1317267C Imide sulfo N-hydroxy maleopimarate as light acid producing agent and its synthetic method
05/22/2007US7220754 Mono-ester and asymmetrically substatuted di-ester pro-drugs of dopamide D1 receptor agonists
05/22/2007US7220741 As cholinergic ligands at the nicotinic acetylcholine receptors and modulators of the monoamine receptors and transporters, for therapy of central nervous system (CNS), the peripheral nervous system (PNS), diseases or disorders related to smooth muscle contraction, endocrine diseases or disorders
05/18/2007WO2007054292A2 Azonafide derivatives, methods for their production and pharmaceutical compositions therefrom
05/18/2007WO2007027719A3 Lisofylline analogues and their pharmeacuetical uses
05/18/2007WO2007016029A3 Diazepinoquinolines, synthesis thereof, and intermediates thereto
05/18/2007WO2007002254A3 Benzocycloheptapyridines as inhibitors of the receptor tyrosine kinase met
05/18/2007CA2629258A1 Azonafide derivatives, methods for their production and pharmaceutical compositions therefrom
05/17/2007US20070112019 9-Azabicyclo[3.3.1]nonane derivatives
05/16/2007EP1785425A2 Novel 1,4-diazabicycloalkane derivatives, their preparation and use
05/16/2007EP1784391A1 Phenanthridine carbonyl phenols as cytokine expression modulators
05/16/2007EP1784186A2 Methods for treating or preventing erectile dysfunction or urinary incontinence
05/16/2007EP1306373B1 3,4-dihydroisoquinoline derivative compounds and drugs containing these compounds as the active ingredient
05/16/2007CN1964976A Extraction of alkaloids from opium
05/16/2007CN1964716A Isoquinoline derivatives and methods of use thereof
05/16/2007CN1964713A Co-administration of dopamine-receptor binding compounds
05/16/2007CN1962660A Process for preparing photoresponsive azobenaene-perylene
05/16/2007CN1962638A Kukoline compound with dextral C circle lacking of morphinan skeleton and its preparation method
05/16/2007CN1315829C Synthesis process of 1,7-disubstituent-3,4:9,10-perylene bisimide
05/16/2007CN1315828C Preparation of 1H-imidazo [4,5-C] quinolin-4-amines via 1H-imidazo [4,5-C] quinolin-4-phthalimide intermediates
05/15/2007US7217736 Esters of 5-aminolevulinic acid as photosensitizing agents in photochemotherapy
05/15/2007US7217709 Tetracyclic benzamide derivatives and methods of use thereof
05/10/2007WO2007051255A1 Process for the preparation of compounds containing an azacyclic ring system
05/10/2007WO2006050265A3 Ceramides and apoptosis-signaling ligand
05/10/2007US20070105899 Benzene compounds
05/10/2007US20070105886 Steroidal compounds for inhibiting steroid sulphatase
05/10/2007DE60119336T2 Verwendungen von thaliporphin oder seinen derivaten in der behandlung von herzkrankheiten und seine herstellung Uses of thaliporphine or its derivatives in the treatment of heart diseases and its production
05/09/2007EP1781672A1 Solvent free amorphous rapamycin
05/09/2007EP1781652A1 Pyrrolopyrimidine and pyrrolopyridine derivatives substituted with tetrahydropyridine as crf antagonists
05/09/2007EP1781616A2 Process for the production of levorphanol and related compounds
05/09/2007EP1781288A2 Modulators of muscarinic receptors
05/09/2007CN1960991A Tetrahydro-imidazo [1,5-A] pyridin derivatives as aldosterone synthase inhibitors
05/09/2007CN1958585A Rutheniumú¿IIú®complexes of second generation DNA molecule optical switch, and preparation method
05/09/2007CN1314688C Pyridinebenzoxazine analog quinolone derivative and its preparation method and uses
05/08/2007US7214685 Antibody directed enzyme prodrug therapy
05/08/2007US7214259 Inks containing water-soluble perylene dyes and their use in ink-jet printing
05/08/2007CA2331870C Novel substituted cyclic compounds, preparation method and pharmaceutical compositions containing them
05/08/2007CA2276098C Tricyclic benzo[e]isoindoles and benzo[h]isoquinolines
05/03/2007WO2007030939A3 Methods of modulating neurotrophin-mediated activity
05/03/2007US20070100033 using N-(2,6-diisopropylphenyl)-4-(4-tert-octylphenoxy)-naphthalene-1,8-dicarboximide to protect living and inanimate organic material such as human or animal skin and hair, paper, foods, perfumes, cosmetics, plastics, polymer dispersions, paints, photo-graphic emulsions, photographic layers
05/03/2007US20070099210 Methods of Labelling Polynucleotides with Dibenzorhodamine Dyes
05/02/2007EP1780203A2 Enantioselective alkylation of tricyclic compounds
05/02/2007CN1956975A Amino cyclopentyl heterocyclic and carbocyclic modulators of chemokine receptor activity
05/02/2007CN1955183A 20-bit esterified camptothecine derivate, its preparation method and drug composite and use
05/02/2007CN1955180A 1,2,3,4,7,8-hexahydro-6H-[1,4]diazepino[6,7,1-IJ] quinoline derivatives as antipsychotic and antiobesity agents
04/2007
04/26/2007WO2007005534A3 Chemical compounds
04/26/2007US20070092441 Fluoridation method
04/26/2007CA2626215A1 Tetrahydroquinolines, synthesis thereof, and intermediates thereto
04/26/2007CA2625877A1 Acylated spiropiperidine derivatives as melanocortin-4 receptor modulators
04/25/2007CN1953982A 4-substituted 1,5-dihydro-pyrido(3,2-b)indol-2-ones
04/25/2007CN1951938A Penehyclidine quaternary ammonium salt and its derivative
1 ... 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 ... 110